<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7503980\results\search\testTrace\results.xml">
  <result pre="attractive drug target. In this study, we used the virtual" exact="screening" post="protocol with both long-range and short-range interactions to select"/>
  <result pre="database and further followed by molecular docking. After in silico" exact="screening" post="of drug space, we identified 57 drugs as potential"/>
  <result pre="further experimental testing. SARS-CoV-2 main protease Mpro drug repurposing virtual" exact="screening" post="ISM 1. Introduction An outbreak of the novel coronavirus"/>
  <result pre="the current study as the target for molecular docking-based virtual" exact="screening" post="(VS) [7]. In this study, we used VS protocol"/>
  <result pre="S8â€&quot;S14 (in the Supplementary Materials). 3. Discussion Current prevention and" exact="treatment" post="options for SARS-CoV-2 infections are insufficient due to lack"/>
  <result pre="applying an innovative concept in selecting candidate molecules for the" exact="treatment" post="of SARS-CoV-2 infection, which includes molecular characteristics responsible for"/>
  <result pre="successive filters. First, the ISM-SM was used for the fast" exact="screening" post="of large compound libraries through candidate selection at a"/>
  <result pre="for the SARS-CoV-2 Mpro. Previously this novel approach in bioinformatics" exact="treatment" post="of small molecules was successfully used for analyzing GPCR"/>
  <result pre="of the advantageous effect of upregulated ACE2, could explain that" exact="treatment" post="with ACE-inhibitors is associated with less severe disease in"/>
  <result pre="with ACE-inhibitors is associated with less severe disease in SARS-CoV-2" exact="infection" post="[31]. A number of drugs selected in our study"/>
  <result pre="with ACE-inhibitors is associated with less severe disease with SARS-Covid-19" exact="infection" post="in a multi-site UK acute Hospital TrustMedrxiv202010.1101/2020.04.07.20056788 32.MahantaS.ChowdhuryP.GogoiN.GoswamiN.BorahD.KumarR.ChetiaD.BorahP.BuragohainA.K.GogoiB.Potential anti-viral"/>
  <result pre="against COVID-19Res. Sq.202010.21203/rs.3.rs-31775/v1 37.TsujiM.Potential anti-SARS-CoV-2 drug candidates identified through virtual" exact="screening" post="of the ChEMBL database for compounds that target the"/>
  <result pre="Library of FDA Approved Drugs Using Molecular Docking StudiesPreprints.org.202010.20944/preprints202004.0149.v1 40.KandeelM.Al-NazawiM.Virtual" exact="screening" post="and repurposing of FDA approved drugs against COVID-19 main"/>
 </snippets>
</snippetsTree>
